Cheyne Capital Management (UK)’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Cheyne Capital Management (UK)’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-41,250	Closed	-$883K	–	65
2022 Q4	$883K	Buy	+41,250	New	+$880K	1.54%	21
2015 Q3	–	Sell	-71,386	Closed	-$3.71M	–	78
2015 Q2	$3.71M	Sell	71,386 -52,765	-43%	-$2.62M	1.2%	13
2015 Q1	$5.78M	Buy	124,151 +32,664	+36%	+$1.7M	1.39%	15
2014 Q4	$4.11M	Buy	91,487 +41,443	+83%	+$1.74M	1.08%	16
2014 Q3	$1.95M	Buy	+50,044	New	+$1.96M	0.69%	20

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cheyne Capital Management (UK)'s ISEE Position: Q1 2023 in Review

Cheyne Capital Management (UK) sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 41,250 shares — an estimated $883K sold.

Cheyne Capital Management (UK) first reported a position in ISEE in Q3 2014 and held it in 5 quarters. The position peaked at $5.78M in Q1 2015. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

Cheyne Capital Management (UK) reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Cheyne Capital Management (UK) sold 41,250 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $883K.
Cheyne Capital Management (UK) first reported a position in IVERIC bio, Inc. Common Stock in Q3 2014 and held it in 5 quarters.
Cheyne Capital Management (UK)'s IVERIC bio, Inc. Common Stock position peaked at $5.78M in Q1 2015.
223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.

Based on Cheyne Capital Management (UK)'s 13F filing for Q1 2023, filed 3 May 2023.